Acutaas Chemicals Subsidiary Stake Reduced to 90%

Acutaas Chemicals Electrolytes Private Limited (ACEPL) ceased to be a wholly owned subsidiary of Acutaas Chemicals Limited after a preferential share allotment.
ACEPL allotted 1,111 equity shares at ₹52,490 per share to A.R.Z Pharma Ltd, raising a total of ₹5.83 crore.
The company's shareholding in ACEPL was diluted from 100% to 90%, though management control remains unchanged.
The transaction was approved by ACEPL's board on May 19, 2026, and disclosed under SEBI LODR Regulation 30.